Fate Therapeutics Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

<p>SAN DIEGO, Dec. 13, 2023 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune disorders, today announced that the Company granted a non-qualified stock option to one newly-hired employee to purchase a […]</p>
<p>The post <a href="https://forextv.com/top-news/fate-therapeutics-reports-new-employee-inducement-grants-under-nasdaq-listing-rule-5635c4/">Fate Therapeutics Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>